Immunoassay Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

1. Executive Summary: Immunoassay
   • Global Market Outlook: Immunoassay
2. Competitive Intelligence Analysis: Immunoassay
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Immunoassay
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Immunoassay
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Immunoassay: Ten Major Market (10MM) – Market Analysis, By Product
   • Reagents & Kits
   • Analyzers/Instruments
   • Software & Services
9. Immunoassay: Ten Major Market (10MM) – Market Analysis, By Technology
   • Radioimmunoassay (RIA)
   • Enzyme Immunoassays (EIA)Rapid Test
   • Others
10. Immunoassay: Ten Major Market (10MM) – Market Analysis, By End User
    • Hospitals
    • Blood Banks
    • Pharmaceutical and Biotech Companies
    • Academic & Research Organizations
    • Others
11. Immunoassay: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

12. S. Immunoassay – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

13. K. Immunoassay – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

14. Germany Immunoassay – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

15. France Immunoassay – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

16. Italy Immunoassay – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

17. Spain Immunoassay – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

18. Japan Immunoassay – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

19. China Immunoassay – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

20. Australia Immunoassay – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

21. India Immunoassay – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Technology
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Technology
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer

Immunoassay Market – Report Overview

Pacific Business Consulting’s “Immunoassay Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Immunoassay market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

The Immunoassay market, with a valuation of US$ 24.0 Billion in 2022, is anticipated to exhibit a Compound Annual Growth Rate (CAGR) exceeding 3.0% from 2023 to 2030, potentially reaching over US$ 30.0 Billion by 2030. The global market’s growth is driven significantly by the rising incidence of infectious and non-infectious diseases, such as diabetes, cardiovascular diseases, cancer, and gastrointestinal diseases. Factors contributing to the increased prevalence of these diseases include alcohol abuse, antimicrobial resistance, smoking, and unhealthy, sedentary lifestyles. Global cancer cases are also on the rise, with the International Agency for Research on Cancer (IARC) projecting over 20 million new cancer cases in 2023.

Furthermore, immunoassay techniques play a crucial role in oncogenesis determination, cancer diagnosis, and the identification of different cancer stages. These techniques enable the use of monoclonal and polyclonal antibodies for detecting specific antigenic molecules in tissues, facilitating the rapid identification of tumor antigens. Consequently, the anticipated increase in cancer cases is expected to propel market growth.

The applications of immunoassay-based diagnostics are expanding rapidly due to the growing awareness among patients globally. Collaborative efforts in scientific awareness and innovation are being fueled by various public and private programs, such as the advocacy program run by the International Society for Infectious Diseases. This surge in scientific awareness is boosting the demand for automated and portable immunoassays, particularly in developing countries.

To enhance efficiency, accuracy, and reduce turnaround time, the market is swiftly adopting automation technologies. Automated systems can handle large sample volumes, leading to increased throughput and decreased error possibilities. The introduction of novel automated point-of-care (POC) analyzers in the market, offering cost-effective testing and the ability to conduct multiple tests, is expected to witness increased adoption. The trend of adopting innovative products has intensified, with the pandemic contributing to the enhanced availability of advanced diagnostic instruments supporting novel assays.

The need for point-of-care technologies is growing due to concerns about infections caused by multidrug-resistant bacteria, frequent disease outbreaks, environmental changes, genetic variations, and population pressure. Point-of-care applications of immunoassays are gaining prominence in the diagnostics space. Market players are strategically launching new products to meet these demands. For example, in March 2023, Quidel Corporation received FDA approval for its novel Sofia 2 SARS Antigen+ FIA, the first rapid antigen test approved for COVID-19 for prescription-based use in point-of-care settings. This approval is expected to enhance Quidel Corporation’s competitiveness and market share.

The market’s growth is further fueled by the increasing incidence of chronic diseases, both infectious and noninfectious, as well as concerns about infections caused by multidrug-resistant bacteria and frequent disease outbreaks in endemic areas. Key players in the Immunoassay segment, including Sysmex Corporation, Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Danaher Corporation (Beckman Coulter), Quidel Corporation, Ortho Clinical Diagnostics, Siemens Healthineers, bioMérieux SA, and Abbott Laboratories, are expected to shape the future landscape of Immunoassay technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Immunoassay market. It also delves into the analysis of present and prospective market competition within the global Immunoassay market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Immunoassay market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Immunoassay market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.